SMAD3-driven cell state transitions underpin immunoresistance in bladder cancer
Sarah Y. T. Robertson, Jing Yang, Neil O. Carragher, Alison F. Munro, Nora Rauch, Thomas Sevrin, Kieran J. Wynne, Walter Kölch, Oleksii S. Rukhlenko, Boris Ν. Kholodenko
The paper identifies SMAD3-driven cell state transitions as a mechanism of immunoresistance in bladder cancer and shows that SMAD3 inhibition sensitizes tumors to T cell-mediated cytotoxicity.
bioRxiv · Oct 22, 2026 · PreprintSystems Biology